Ollection (group II) (Fig 8). RT-PCR was performed using total RNA extracted from the corneas in groups II and III as the template. The PCR products were analysed by agarose gel electrophoresis. Exogenous IL-1ra mRNA was expressed in the grafts, suggesting that hIL-1ra protein was expressed from the transcription, translation, and synthesis of hIL-1ra cDNA transfected into the cornea. In addition, at postoperative day 6, the mRNA expression in group II was higher than in group III (Fig 9).Detection of IL-1a and IL-1b in corneal graftsDuring acute corneal rejection, IL-1a and IL-1b expression in the IL-1ra gene treatment groups was lower than that in the negative control group (P,0.05), and there was no significant difference between the IL-1ra treatment groups (P = 0.292 andFigure 3. HE purchase Ergocalciferol staining at 2 weeks after corneal transplantation. A, Obvious graft oedema, inflammatory cell infiltration and neovascularisation (blue arrow) in the stroma were observed in the group I. BD(group II,group IV), Mild oedema and reduced lymphocyte infiltration and neovascularisation were observed in the IL-1ra gene treatment groups. (6200). doi:10.1371/journal.pone.0060714.gFigure 4. TGF-b1 expression in the corneal grafts. TGF-b1 is shown by dark brown staining (dark arrows) in the cytoplasm. B?D,(group II,group IV), the quantity of positive inflammatory cells was lower than that of the grafts in the A (group I). (6200). doi:10.1371/journal.pone.0060714.gCorneal Graft Rejection with the IL-1ra GeneFigure 5. RANTES expression in the corneal grafts. RANTES was expressed 18204824 in the cell membrane and cytoplasm and is shown by dark brown staining (dark arrows). The expression intensities of RAb1NTES in the group I(A) were increased compared to groups II, III and IV(B-D). (6200). doi:10.1371/journal.pone.0060714.gFigure 6. The expression of CD4+cells in the corneal graft. During acute corneal rejection, increased CD4+ cells were observed in all of the groups compared to pre-operation. Brownish-yellow staining in the cytoplasm can be observed(black and blue arrow). The numbers of CD4+ cells in the group I (A)were higher than other groups. There was no significant difference between treatment groups(B-D) (6400). doi:10.1371/journal.pone.0060714.gDiscussionCorneal graft rejection is a complex process. Evaluation of the mechanisms and treatment of graft rejection is important to improving the success of corneal transplantation. The Wistar-SD rat model used in this study is a high-risk corneal transplant model [11] in which donor rejection generally occurs 7 days after surgery, peaks between 10 and 14 days, and manifests with rapid corneal neovascularisation. IL-1 is one of the key cytokines in corneal transplant rejection [13?4]. After stimulating corneal epithelial cells and corneal stromal cells with IL-1, studies have shown that the monocyte chemotactic factor secreted by corneal stromal cells increases 150 fold [4]. Niederkorn [15] demonstrated that Langerhans cells moved towards the centre of the cornea 30 minutes after injecting IL-1 into the cornea and mononuclear cells that infiltrated the cornea promoted antigen presentation and activated immune rejection. CB 5083 Currently, the study of IL-1ra in the field of ophthalmology is in the early phase. Dana [8] reported that the topical application of 2 IL-1ra formulated in a hyaluronic acid vehicle blocked the activity of IL-1 in a mouse model of keratoplasty. The mean suppression of leukocyte infiltration after transplant.Ollection (group II) (Fig 8). RT-PCR was performed using total RNA extracted from the corneas in groups II and III as the template. The PCR products were analysed by agarose gel electrophoresis. Exogenous IL-1ra mRNA was expressed in the grafts, suggesting that hIL-1ra protein was expressed from the transcription, translation, and synthesis of hIL-1ra cDNA transfected into the cornea. In addition, at postoperative day 6, the mRNA expression in group II was higher than in group III (Fig 9).Detection of IL-1a and IL-1b in corneal graftsDuring acute corneal rejection, IL-1a and IL-1b expression in the IL-1ra gene treatment groups was lower than that in the negative control group (P,0.05), and there was no significant difference between the IL-1ra treatment groups (P = 0.292 andFigure 3. HE staining at 2 weeks after corneal transplantation. A, Obvious graft oedema, inflammatory cell infiltration and neovascularisation (blue arrow) in the stroma were observed in the group I. BD(group II,group IV), Mild oedema and reduced lymphocyte infiltration and neovascularisation were observed in the IL-1ra gene treatment groups. (6200). doi:10.1371/journal.pone.0060714.gFigure 4. TGF-b1 expression in the corneal grafts. TGF-b1 is shown by dark brown staining (dark arrows) in the cytoplasm. B?D,(group II,group IV), the quantity of positive inflammatory cells was lower than that of the grafts in the A (group I). (6200). doi:10.1371/journal.pone.0060714.gCorneal Graft Rejection with the IL-1ra GeneFigure 5. RANTES expression in the corneal grafts. RANTES was expressed 18204824 in the cell membrane and cytoplasm and is shown by dark brown staining (dark arrows). The expression intensities of RAb1NTES in the group I(A) were increased compared to groups II, III and IV(B-D). (6200). doi:10.1371/journal.pone.0060714.gFigure 6. The expression of CD4+cells in the corneal graft. During acute corneal rejection, increased CD4+ cells were observed in all of the groups compared to pre-operation. Brownish-yellow staining in the cytoplasm can be observed(black and blue arrow). The numbers of CD4+ cells in the group I (A)were higher than other groups. There was no significant difference between treatment groups(B-D) (6400). doi:10.1371/journal.pone.0060714.gDiscussionCorneal graft rejection is a complex process. Evaluation of the mechanisms and treatment of graft rejection is important to improving the success of corneal transplantation. The Wistar-SD rat model used in this study is a high-risk corneal transplant model [11] in which donor rejection generally occurs 7 days after surgery, peaks between 10 and 14 days, and manifests with rapid corneal neovascularisation. IL-1 is one of the key cytokines in corneal transplant rejection [13?4]. After stimulating corneal epithelial cells and corneal stromal cells with IL-1, studies have shown that the monocyte chemotactic factor secreted by corneal stromal cells increases 150 fold [4]. Niederkorn [15] demonstrated that Langerhans cells moved towards the centre of the cornea 30 minutes after injecting IL-1 into the cornea and mononuclear cells that infiltrated the cornea promoted antigen presentation and activated immune rejection. Currently, the study of IL-1ra in the field of ophthalmology is in the early phase. Dana [8] reported that the topical application of 2 IL-1ra formulated in a hyaluronic acid vehicle blocked the activity of IL-1 in a mouse model of keratoplasty. The mean suppression of leukocyte infiltration after transplant.
